Eib Tf 2,75% St25 Eur (739767) News

Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm

Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm PR Newswire NEW YORK, May 22...

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update

ARCA biopharma and Oruka Therapeutics announce Merger AgreementARCA biopharma appoints Thomas Keuer as...

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm PR Newswire NEW YORK, April 5...

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement

Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 8-K - Current report

Form 8-K - Current report

ARCA biopharma Announces 2023 Financial Results

Company is currently engaged in a strategic review process, evaluating additional development of its assets...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities